CervoMed Inc. Finite-Lived Intangible Assets, Accumulated Amortization
CervoMed Inc. (CRVO) had Finite-Lived Intangible Assets, Accumulated Amortization of $962.34 thousand as of 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2015-04-03
- 2014-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $962.34K.
- 2014-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $595.32K.
- 2013-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $87.32K.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2014-09-30 | $962.34K 10-Q · filed 2014-11-12 |
| 2014-06-30 | $595.32K 10-Q · filed 2014-08-14 |
| 2013-12-31 | $87.32K 10-K · filed 2015-04-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |